Twin Focus Capital Partners’s Cullinan Oncology CGEM Stock Holding History

Twin Focus Capital Partners’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.8M	Hold	595,489	–	–	1.1%	25
2026 Q1	$8.46M	Hold	595,489	–	–	0.97%	26
2025 Q4	$6.16M	Hold	595,489	–	–	0.71%	37
2025 Q3	$3.53M	Hold	595,489	–	–	0.45%	45
2025 Q2	$4.48M	Hold	595,489	–	–	0.63%	36
2025 Q1	$4.51M	Hold	595,489	–	–	0.7%	37
2024 Q4	$7.25M	Hold	595,489	–	–	1.07%	26
2024 Q3	$9.97M	Hold	595,489	–	–	1.57%	19
2024 Q2	$10.4M	Buy	+595,489	New	+$12.7M	1.66%	15

Other funds holding CGEM

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Twin Focus Capital Partners's CGEM Position: Q2 2026 in Review

Twin Focus Capital Partners held its Cullinan Oncology (CGEM) position steady in Q2 2026 at 595,489 shares worth $10.8M. The position accounts for 1.1% of the portfolio, ranked #25.

Twin Focus Capital Partners first reported a position in CGEM in Q2 2024 and has held it in 9 quarters since. 184 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

Twin Focus Capital Partners held 595,489 shares of Cullinan Oncology worth $10.8M as of Q2 2026.
Twin Focus Capital Partners left its Cullinan Oncology share count unchanged in Q2 2026.
Cullinan Oncology made up 1.1% of Twin Focus Capital Partners's portfolio in Q2 2026, its #25 holding.
Twin Focus Capital Partners first reported a position in Cullinan Oncology in Q2 2024 and has held it in 9 quarters since.
184 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Twin Focus Capital Partners's 13F filing for Q2 2026, filed 28 Jul 2026.